Showing results (1-10 of 298) with videos related to
Sort By:
Pageof 30
Annals of Neurology|May 1, 1995
Ocular neuromyotonia: clinical features, physiological mechanisms, and response to therapyE M Frohman, D S ZeeObstetrics and Gynecology Clinics of North America|June 30, 2001
Diagnosis and management of headacheJ B Lewis, E M FrohmanVision Research|December 1, 1995
Gap-overlap effects on latencies of saccades, vergence and combined vergence-saccades in humansM Takagi, E M Frohman, D S ZeeMultiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphismsE M Frohman, E Havrdova, B Levinson, et al.The Journal of Urology|February 18, 1999
Multiple sclerosis and the urologistS E Litwiller, E M Frohman, P E ZimmernJournal of Clinical Immunology|January 1, 1989
Astrocytes and intracerebral immune responsesE M Frohman, S van den Noort, S GuptaAnnals of Neurology|April 1, 1996
Vestibular dysfunction in chronic inflammatory demyelinating polyneuropathyE M Frohman, R Tusa, A S Mark, et al.Journal of Neuroimmunology|January 1, 1988
Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytesE M Frohman, B Vayuvegula, S van den Noort, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanismsE M Frohman, B Vayuvegula, S Gupta, et al.Pageof 30